We are SO proud of all 6 of our senior research assistants for all of their incredible work at Tisch MSRCNY! This amazing group of RA's are starting their next chapters at Albert Einstein College of Medicine, SUNY Downstate College of Medicine, Tufts University, Boston University's Chobanian and...
We are very excited to share that the highly-anticipated Phase II results of our FDA-approved stem cell treatment study have been released. Building off the groundbreaking findings in Phase I, this is the first study to show a broad array of regenerative improvements, and have very exciting...
Stem cell therapy reduces symptoms of progressive MS for some people After experimental stem cell therapy, people who required assistance walking due to symptoms of progressive multiple sclerosis saw their mobility improve By Grace Wade 19 May 2023 An experimental stem cell therapy may reduce some...
Results, however, indicated that MSC-NP improved walking ability for people with more advanced disease — those who need an aid to walk short distances. Patients treated with MSC-NP also often reported fewer bladder problems following treatment. “The findings of this study suggest that stem cells...
We’re excited to share that our Center was featured in an article in The New Yorker! Drawing from interviews with some of our patients, our Principal Investigators, and Dr. Sadiq, the piece highlights how our comprehensive approach to MS research has led to some of the most significant recent...
Advancing multiple sclerosis with cerebral organoids: an interview with Nicolas Daviaud With this year marking ten years since the development of cerebral organoids, we spoke to Nicolas Daviaud to learn how the Tisch Multiple Sclerosis Research Center of New York (USA) is using them as a model for...